Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT03362385 Completed - Clinical trials for Acute Coronary Syndrome

OSA-ACS Project: Association of OSA and CPAP Therapy With Outcomes in ACS Patients

Start date: May 2015
Phase:
Study type: Observational

Obstructive sleep apnea (OSA) is an increasingly common chronic disorder in adults that has been strongly associated with various forms of cardiovascular disease. Compared to the general population, OSA occurs more often in patients with acute coronary syndrome (ACS). Although percutaneous coronary intervention (PCI) is nowadays part of standard therapy and optimal medical therapy has been used to manage traditional risk factors, the long-term cardiovascular outcomes after index ACS remain suboptimal. Some preliminary data suggest OSA is associated with higher risk of subsequent cardiovascular events in ACS patients. However, the study population was heterogeneous and these studies were not done in the context of new-generation drug-eluting stents and intensive antiplatelet therapy, thus precluding definite conclusions. Furthermore, a cardioprotective role of OSA in the context of acute myocardial infarction (AMI), via ischemic preconditioning, has also been postulated. Due to the inconsistent evidence, the investigators performed a large-scale, prospective cohort study to delineate the whole picture of the association of OSA with short- and long-term outcomes of patients with ACS. Whether treatment of OSA (eg. continuous positive airway pressure (CPAP)) would prevent these events will also be evaluated. Moreover, the investigators will assess the potential mechanisms of OSA-induced atherosclerosis and myocardial injury in ACS patients.

NCT ID: NCT03360747 Completed - Clinical trials for Familial Chylomicronemia Syndrome

Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)

Start date: December 21, 2017
Phase: Phase 2
Study type: Interventional

This is a single center, open-label study to evaluate the efficacy of AKCEA-ANGPTL3-LRx for reduction of triglyceride (TG) levels in participants with FCS.

NCT ID: NCT03360344 Completed - Clinical trials for Carpal Tunnel Syndrome, Susceptibility to

Non-surgical Intervention for Carpal Tunnel Syndrome

Start date: February 8, 2018
Phase: N/A
Study type: Interventional

This randomized controlled trial graduate student research study will explore the effect of non-surgical intervention of the dorsal application of Kinesio Tape for carpal tunnel syndrome, and forearm wrist hand pain.

NCT ID: NCT03360136 Completed - Clinical trials for Burnout, Professional

Open Clinical Trial of CBT-based Multiprofessional Rehabilitation for Exhaustion Disorder

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Stress-related mental disorders are today the leading cause of long-term sick leave in Sweden, and a large part of this increase is due to Clinical burnout, in Sweden called "Exhaustion disorder" (ED). Even though clinical guidelines recommend multi-professional rehabilitation (MPR) for ED, few studies have evaluated the effects of these treatment programs in clinical practice. This large-scale open clinical trial investigates whether MPR for ED seems to alleviate symptoms of ED and if it results in return-to-work.

NCT ID: NCT03359499 Completed - Clinical trials for Irritable Bowel Syndrome

Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients

Start date: August 12, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Probiotics have been proposed as useful therapeutic alternatives for the treatment of irritable bowel syndrome patients. Bacillus clausii is a probiotic that has been used for the treatment of acute diarrhea among adults and pediatric patients, as well as an adjunctive therapy for the treatment for Helicobacter pylori infection. It has been proposed that Bacillus clausii is effective for the treatment of irritable bowel syndrome-related symptoms (especially diarrhea and bloating) in non-controlled trials. The aim of the proposed investigation is to determine whether the administration of Bacillus clausii during two weeks plus dietary advice compared to antispasmodics plus dietary advice would be an effective and safe alternative.

NCT ID: NCT03359460 Completed - Clinical trials for Myelodysplastic Syndrome

Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome

Start date: December 1, 2017
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of ibrutinib when giving together with lenalidomide in treating patients with myelodysplastic syndrome. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving ibrutinib and lenalidomide may work better in treating patients with myelodysplastic syndrome.

NCT ID: NCT03359135 Not yet recruiting - Clinical trials for Hypermobility Type Ehlers-Danlos Syndrome

Compression Garments on Hypermobility Type of Ehlers-Danlos Syndrome (CGhEDS)

VECO
Start date: April 1, 2018
Phase: N/A
Study type: Observational

This study evaluates the effects of wearing a compression garment on the postural balance of patients with hypermobility type of Ehlers-Danlos syndrome, in randomised controlled study.

NCT ID: NCT03359031 Enrolling by invitation - Clinical trials for Compartment Syndrome of Leg

Effects of Perioperative Patient Education Regarding Compartment Syndrome on Post-operative Opioid Consumption

Start date: November 13, 2017
Phase: N/A
Study type: Interventional

This study is a prospective, randomized trial. Our study aims to study the effects of perioperative patient education about compartment syndrome on patients' perception of their own pain, amount of opioid medication utilization, and rate of diagnosis of compartment syndrome.

NCT ID: NCT03358979 Recruiting - Dry Eye Syndromes Clinical Trials

Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)

ALTESSE
Start date: December 14, 2017
Phase:
Study type: Observational

Modifications of cell surface markers (including EMMPRIN) were observed in conjunctival epithelial cells during dry eye syndrome ; this study aims to describe the modifications of the repartition of these cell surface markers before and after initiation of a treatment.

NCT ID: NCT03358823 Completed - Angelman Syndrome Clinical Trials

Study on the Brain Network of Angelman Syndrome

Start date: May 20, 2017
Phase:
Study type: Observational [Patient Registry]

The aims of study on Angelman syndrome: 1. Establish the Angelman syndrome database 2. Explore the brain Network of Angelman Syndrome Based on Multi-modal Brain Image and Neural-EEG Data